Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
25 6月 2020
CJEU rules that providing free samples of non-prescription drugs to pharmacists is permitted
18 6月 2020
Future Cities Series: How planning and zoning rules can drive post-Covid development
9 6月 2020
Governance: Corporate Insolvency and Governance Bill: impact on supply chains and their customers (UK)
26 5月 2020
Manufacturing medicines in Australia: examining the need for increased domestic capability
12 5月 2020
Patent and Pharma Update, May 2020
29 4月 2020
Commonwealth fails in its claim for compensation for PBS expenditure
23 4月 2020
COVID-19: People: Contact Tracing – balancing civil liberties (Australia)
21 4月 2020
COVID-19: ÁREAS DE IMPACTO: Últimas novedades en el sector farmacéutico y salud (España)
14 4月 2020
Exploring Opportunities: The impact of Covid-19 on competition law in the pharmaceutical sector (Europe)
7 4月 2020
COVID-19: Pressure points: Online sales of pharmaceuticals – now available? (Russia)
17 3月 2020
COVID-19: Potential legal impact (Spain)
3 3月 2020
Directors and ESG disclosure – The risks will only get bigger
